Table 3 from Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Melanoma: AMBER Cohorts 1c, 1e, and 2A
收藏Figshare2025-08-14 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_3_from_Combined_Targeting_of_PD-1_and_TIM-3_in_Patients_with_Locally_Advanced_or_Metastatic_Melanoma_AMBER_Cohorts_1c_1e_and_2A/29908276
下载链接
链接失效反馈官方服务：
资源简介：
ORR, DCR, and BOR in patients treated with cobolimab 100, 300, or 900 mg plus dostarlimab.
创建时间：
2025-08-14
